Resonate Blends, Inc. (KOAN)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.00
- As of
Kresmion compiles this page from KOAN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Resonate Blends, Inc. (KOAN): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2025-06-16.
See the full KOAN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for KOAN on one page. Preview it with sample data, then open it live with a free account.
Preview the KOAN dossierActive signals for KOAN
- mediumEARNINGS_MISS
Q1-2003: Missed consensus by 26.5% - EPS $1200 vs $1632 estimate
- mediumEARNINGS_MISS
Q2-2003: Missed consensus by 82.2% - EPS $200 vs $1122 estimate
- mediumEARNINGS_MISS
Missed consensus by 26.5% - EPS $1200 vs $1632 estimate
- mediumEARNINGS_MISS
Missed consensus by 82.2% - EPS $200 vs $1122 estimate
FREE, NO ACCOUNT
Every signal on KOAN, as it fires
New filings, 13F moves and cross asset signals on KOAN land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, KOAN
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
KOAN against its peers
KOAN's operating margin of -89.5% ranks in the 59th percentile of 10 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2024-06-30 and 2025-03-31.
| Metric | KOAN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.9M USD | 968795 USD | 65 | 12 |
| Gross margin | 65.2% | 40.5% | 63 | 11 |
| Operating margin | -89.5% | -129.1% | 59 | 10 |
| Net margin | -112.5% | -191.2% | 58 | 12 |
| 1 year | -98.3% | -53.0% | 21 | 6 |
Peers (13): PNXP, GRPS, STEK, GCAN, CBDY, BSPK, OWPC, AYRWF, NPHC, KAYS, CPMD, SXTC, PCYN. Left out: XTXXF (period gap), PTPI (period gap), BNIGF (no annual filing), FITY (no annual filing), NTRR (period gap), SKYI (period gap), GREH (no annual filing), SFWJ (no annual filing), NASC (period gap), CBDL (no annual filing), SBFM (period gap), CANN (period gap). Fiscal periods ending between 2024-06-30 and 2025-03-31. Every figure is one full fiscal year read from one annual filing (KOAN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow KOAN on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to KOAN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.